On the road to hu­man stud­ies, next-gen gene edit­ing con­tender Metageno­mi hauls in an ex­tra $100M

One of the up-and-com­ers in the gene edit­ing field is bank­ing an ex­tra $100 mil­lion and boost­ing their B round to a hefty $275 mil­lion.

The ex­tra fund­ing caps what was a busy year for Metageno­mi in 2022, in­clud­ing a fresh re­search al­liance with Io­n­is about six weeks ago that came with an $80 mil­lion up­front. The biotech ear­li­er tied up with mR­NA pi­o­neer Mod­er­na in an at­ten­tion-grab­bing part­ner­ship.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER